Why the study?
The impact of diabetes mellitus on baseline and post-treatment arterial stiffness in patients with primary aldosteronism was unknown.
Does the presence of diabetes mellitus impair the post-treatment recovery of arterial stiffness in patients with primary aldosteronism?
Population
1071 PA patients (177 with diabetes and 894 without)
Comparison
Diabetes mellitus vs no diabetes mellitus
Design
Prospective cohort study with propensity score matching
Follow-up
1 year
Authors
Loading...
Diabetes may blunt arterial stiffness recovery after PA treatment; hypothesis-generating for glycemic optimization effects.
Does the presence of diabetes mellitus impair the post-treatment recovery of arterial stiffness in patients with primary aldosteronism?
In patients with primary aldosteronism, concurrent diabetes mellitus is associated with worse baseline arterial stiffness and blunted vascular recovery after 1 year of targeted therapy.
Tsai et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: